Wednesday, September 9, 2026
spot_img

Journey Medical Corporation to Participate in September 2026 Investor Conferences

SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on developing, selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in two September 2026 investor conferences.

Details of the events are as follows:

Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference
Date: Thursday, September 10, 2026
Location: New York City
Format: 1×1 Meetings

H.C. Wainwright 28th Annual Global Investment Conference
Date and Time: Monday, September 14, 2026, at 10:00 a.m. ET
Location: New York City
Format: Presentation and 1×1 Meetings

A webcast of the Company’s presentation at H.C. Wainwright will be available on the News and Events page of the Investors section of Journey Medical’s website, www.journeymedicalcorp.com, for approximately 30 days after the meeting.

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets nine branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and the company files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
[email protected]

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
[email protected]

Powered by SlickText.com

Hot this week

OSL Group Partners with Waka to Power Stablecoin Settlement for Emerging Market Trade

OSL will integrate stablecoin-to-USD fiat conversion and USD payout...

AGM Date and Director Nominations

PERTH, Australia, Sept. 08, 2026 (GLOBE NEWSWIRE) --...

Mission Produce® Announces Fiscal 2026 Third Quarter Financial Results

Revenue of $450 million reflects 26% increase over prior...

Carlsmed, Inc. Announces Chief Operating Officer Appointment

CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) --...

ServiceTitan Announces Fiscal Second Quarter Financial Results

LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) --...

Topics

OSL Group Partners with Waka to Power Stablecoin Settlement for Emerging Market Trade

OSL will integrate stablecoin-to-USD fiat conversion and USD payout...

AGM Date and Director Nominations

PERTH, Australia, Sept. 08, 2026 (GLOBE NEWSWIRE) --...

Mission Produce® Announces Fiscal 2026 Third Quarter Financial Results

Revenue of $450 million reflects 26% increase over prior...

Carlsmed, Inc. Announces Chief Operating Officer Appointment

CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) --...

ServiceTitan Announces Fiscal Second Quarter Financial Results

LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) --...

ServiceTitan Names Rikus Pretorius Next Chief Revenue Officer

ServiceTitan Veteran Promoted to Lead Sales Organization Through Next...

Barnes & Noble Education Reports Fiscal 2027 First Quarter Financial Results

Quarterly Results Reflect Improved Profitability, First Day® Complete Growth...
spot_img

Related Articles

Popular Categories

spot_img